Company intelligence / Profile preview

BioSante Canadian Pharmaceuticals

Lincolnshire, Illinois, United States

Ownership: Private
Development stage: Other

Overview

BioSante Pharmaceuticals was a specialty pharmaceutical company primarily focused on developing products for women's health and oncology. The company's portfolio featured Elestrin, an FDA-approved estradiol gel for menopausal symptoms, and LibiGel, a testosterone gel candidate for female sexual dysfunction. Additionally, BioSante developed vaccine adjuvants and cancer vaccines through its proprietary technologies. In July 2013, the company merged with ANI Pharmaceuticals, transitioning its operations and pipeline into the combined entity.

Therapeutic areas: OncologyEndocrinologyWomen's Health
Modalities: Small moleculeHormoneVaccine
Industry: Biotech

Partnerships

Teva PharmaceuticalsMeda PharmaceuticalsJazz Pharmaceuticals

Beyond the preview

Go deeper on BioSante Canadian Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSante Canadian Pharmaceuticals.

Explore the full profile